US FDA Approves Inovio Treatment
The US Food and Drug Administration approved Inovio Pharmaceuticals therapy for a rare respiratory condition, marking the company first approved product and sending shares higher.
Xurve View
Insights:
Xurve View
Inovio Pharmaceuticals secured United States regulatory clearance for Voceryq, sending shares up 257% in extended trading. The approval marks the first commercial product for the biotechnology firm.
